Doug Frandsen

CNS pipeline · person

Doug Frandsen

Corporate Controller at Emalex Biosciences, responsible for financial accounting and reporting, budgeting, tax, and financial controls. He brings nearly 20 years of financial experience; most recently he served as U.S. Controller for Orphazyme, and previously held finance and accounting roles at Baxter International, Baxalta, Shire and Takeda. He holds a Master of Accounting Science and a Bachelor of Accounting Science from the University of Illinois, Urbana-Champaign.

  • 1 company

Courtesy Emalex Biosciences

Current roles

Appears with

People sharing a company with Doug.

People and affiliation data assembled from public company disclosures, SEC filings, and conference materials — every record source-cited under psychiatrist-authored guardrails.